Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung Chan

Showing results (351-360 of 362) with videos related to

Pageof 37
Sort By:
Human Pathology|August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaSamantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Molecular Cell|April 20, 2021
Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancerTeresa Sadras, Mickaël Martin, Kohei Kume, et al.
Diabetes|September 28, 2005
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9George R Lankas, Barbara Leiting, Ranabir Sinha Roy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal CancerCaroline Even, Hung-Ming Wang, Shau-Hsuan Li, et al.
JACC. Cardiovascular Imaging|March 14, 2024
Development and Validation of a Quantitative Coronary CT Angiography Model for Diagnosis of Vessel-Specific Coronary IschemiaNick S Nurmohamed, Ibrahim Danad, Ruurt A Jukema, et al.
Journal of Medicinal Chemistry|June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemiaRenata M Oballa, Liette Belair, W Cameron Black, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitorDwight Macdonald, Anthony Mastracchio, Hélène Perrier, et al.
The Lancet Regional Health. Western Pacific|September 13, 2023
Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trialChi Leung Chiang, Tai Chung Lam, James Chun Bong Li, et al.
Protein Engineering, Design & Selection : PEDS|December 22, 2009
Engineering of stable bispecific antibodies targeting IL-17A and IL-23Robert Mabry, Katherine E Lewis, Margaret Moore, et al.
Pageof 37

Showing results (351-360 of 362) with videos related to

Sort By:
Pageof 37
Human Pathology|August 6, 2014
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphomaSamantha L Kendrick, Lucas Redd, Andrea Muranyi, et al.
Molecular Cell|April 20, 2021
Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancerTeresa Sadras, Mickaël Martin, Kohei Kume, et al.
Diabetes|September 28, 2005
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9George R Lankas, Barbara Leiting, Ranabir Sinha Roy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal CancerCaroline Even, Hung-Ming Wang, Shau-Hsuan Li, et al.
JACC. Cardiovascular Imaging|March 14, 2024
Development and Validation of a Quantitative Coronary CT Angiography Model for Diagnosis of Vessel-Specific Coronary IschemiaNick S Nurmohamed, Ibrahim Danad, Ruurt A Jukema, et al.
Journal of Medicinal Chemistry|June 14, 2011
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemiaRenata M Oballa, Liette Belair, W Cameron Black, et al.
Blood|September 17, 2013
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphomaAlyssa Bouska, Timothy W McKeithan, Karen E Deffenbacher, et al.
Bioorganic & Medicinal Chemistry Letters|September 20, 2005
Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitorDwight Macdonald, Anthony Mastracchio, Hélène Perrier, et al.
The Lancet Regional Health. Western Pacific|September 13, 2023
Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trialChi Leung Chiang, Tai Chung Lam, James Chun Bong Li, et al.
Protein Engineering, Design & Selection : PEDS|December 22, 2009
Engineering of stable bispecific antibodies targeting IL-17A and IL-23Robert Mabry, Katherine E Lewis, Margaret Moore, et al.
Pageof 37